Amalgamated Bank’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-745
Closed -$10K 2859
2025
Q4
$10K Buy
745
+331
+80% +$2.93K ﹤0.01% 2442
2025
Q3
$2K Hold
414
﹤0.01% 2957
2025
Q2
$2K Hold
414
﹤0.01% 2982
2025
Q1
$2K Hold
414
﹤0.01% 2889
2024
Q4
$2K Buy
+414
New +$7.14K ﹤0.01% 2933

Other funds holding BIOA

Amalgamated Bank's BIOA Position: Q1 2026 in Review

Amalgamated Bank sold out of BioAge Labs (BIOA) in Q1 2026, closing a stake of 745 shares — an estimated $10K sold.

Amalgamated Bank first reported a position in BIOA in Q4 2024 and held it in 5 quarters. The position peaked at $10K in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Amalgamated Bank reported no remaining BioAge Labs position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 745 BioAge Labs shares in Q1 2026, an estimated $10K.
  • Amalgamated Bank first reported a position in BioAge Labs in Q4 2024 and held it in 5 quarters.
  • Amalgamated Bank's BioAge Labs position peaked at $10K in Q4 2025.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.